Hikaru Yoneda

  • Citations Per Year
Learn More
T-1095, an orally active inhibitor of Na(+)-glucose cotransporter (SGLT), excretes excess plasma glucose into urine, lowers blood glucose levels, and thus has therapeutic potential for treatment of(More)
  • 1